Feilun Cui
Overview
Explore the profile of Feilun Cui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
139
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu Z, Xu X, Hu J, Tan J, Wan Y, Cui F
Transl Cancer Res
. 2024 Aug;
13(7):3575-3588.
PMID: 39145061
Background: The relationship between lipid metabolism, immune response, and immunotherapy in prostate cancer (PCa) is closely intertwined, and targeted intervention in lipid metabolism may facilitate the success of anticancer immunotherapy....
2.
Cui F, Tang X, Man C, Fan Y
BMC Cancer
. 2024 May;
24(1):628.
PMID: 38783246
Background: The 17-gene Genomic Prostate Score (GPS) test has been clinically employed to predict adverse prognosis in prostate cancer. In this meta-analysis, we aimed to evaluate the prognostic value of...
3.
Yao M, Mao X, Zhang Z, Cui F, Shao S, Mao B
Front Cell Dev Biol
. 2024 Mar;
12:1289538.
PMID: 38523627
Non-coding RNAs play important roles in tumor cells and macrophages and participate in their communication as messengers. Non-coding RNAs have an impact in tumor cell proliferation, migration, and apoptosis, and...
4.
Cui F, Qiu Y, Xu W, Zou C, Fan Y
Nutr Cancer
. 2024 Mar;
76(5):395-403.
PMID: 38477679
Studies on the prognostic value of the blood 25-hydroxyvitamin D level have yielded controversial results in prostate cancer (PCa) patients. This updated meta-analysis aimed to evaluate the association between pretreatment...
5.
Cui F, Qiu Y, Xu W, Zou C, Fan Y
BMC Cancer
. 2024 Mar;
24(1):305.
PMID: 38448818
Background: A consensus has not been reached on the value of prostate-specific antigen density (PSAD) as a predictor of biochemical recurrence of prostate cancer. This meta-analysis aimed to evaluate the...
6.
Zhao W, Yao Z, Cao J, Liu Y, Zhu L, Mao B, et al.
J Cancer Res Clin Oncol
. 2024 Feb;
150(2):104.
PMID: 38407616
Purpose: Helicobacter pylori (H. pylori) has unique biochemical traits and pathogenic mechanisms, which make it a substantial cause of gastrointestinal cancers. Circular RNAs (circRNAs) have concurrently been identified as an...
7.
Cui F, Qiu Y, Xu W, Shan Y, Liu C, Zou C, et al.
Heliyon
. 2024 Feb;
10(4):e25728.
PMID: 38390166
Objective: This meta-analysis aimed to assess the influence of comorbidity, as assessed by the Charlson comorbidity index (CCI), on survival outcomes in patients with prostate cancer (PCa). Methods: We conducted...
8.
Yao M, Mao X, Zhang Z, Xi Y, Gan H, Cui F, et al.
Cell Cycle
. 2023 Oct;
22(18):2003-2017.
PMID: 37872772
Background: Gastric cancer is a common malignant tumor of the digestive tract and the fourth leading cause of death from cancer-related diseases. In recent years, many studies have found that...
9.
Zhu L, Yao Z, Luo Q, Liu Y, Zhao W, Shao C, et al.
Int J Med Sci
. 2023 Jul;
20(8):1038-1045.
PMID: 37484805
GRB10 interacting GYF protein 1 (GIGYF1) binds to the N-terminal region of Grb10, regulates multiple signaling pathways. However, it is not clear what happens to cell proliferation, metastasis, apoptosis, and...
10.
Cui F, Xu Z, Hu J, Lv Y
Front Immunol
. 2022 Aug;
13:907636.
PMID: 35967419
Tumor-associated macrophages (TAMs) are involved in the growth of prostate cancer (PrC), while the molecular mechanisms underlying the interactive crosstalk between TAM and PrC cells remain largely unknown. Platelet-derived growth...